関連する実験動画
Updated: Sep 9, 2025

08:47
Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
3.2K
RNF126は,HEK293T細胞におけるILF3をユビキチン化することによって,アミノ酸媒介のmTORC1信号経路を抑制する
Bin Hu1, Meng-Di Shang2, Xi Wang3
1The First School of Clinical Medicine, Binzhou Medical University, Binzhou, Shandong 256603, PR China.
Cellular signalling
|September 4, 2025
まとめ
RNF126は,ILF3をユビキナイトすることによって,mTORC1経路をネガティブに調節する. この発見は 細胞の成長を制御する新しいメカニズムを明らかにし 乳がんの潜在的治療目標を提供します
科学分野:
- 細胞の代謝
- 信号伝達経路
- 腫瘍学研究
背景:
- ラパミシン複合体1 (mTORC1) の哺乳類標的は,細胞の成長を促進する重要な代謝調節体であり,その過剰活性化は癌の進行と関連しています.
- 栄養素検出の際にGATOR複合体と相互作用することで,mTORC1の負の調節剤として作用する.
- mTORC1シグナル伝達におけるILF3の役割を規定する正確な規制メカニズムは完全に理解されていません.
研究 の 目的:
- ILF3媒介 mTORC1シグナル伝達経路の制御メカニズムを解明する.
- ILF3とmTORC1のシグナル伝達におけるRNF126の役割を調査する.
- 乳がんモデルでこの経路を標的とした治療の可能性を評価する.
主な方法:
- RNF126,ILF3,およびGATOR複合体の相互作用を研究するために,HEK293T細胞を使用した.
- ILF3に対するRNF126の効果を評価するために,ユビキチネーションアッセイを行った.
- RNF126の減少が腫瘍の進行に与える影響を評価するために,臨床前のモデルでMCF7の乳がん細胞を使用した.
主要な成果:
- RNF126は,ILF3のK63結合ユビキチネーションを通じてmTORC1のシグナリングをネガティブに調節することを実証した.
- ILF3とGATOR2複合体の相互作用を妨害することが示された.
- 臨床前モデルでは,RNF126の減少が乳がんの進行を抑制することが観察されました.
結論:
- RNF126は,ILF3のユビキチネーションとGATOR複合体との相互作用を調節することによって,mTORC1の新たな負の調節剤として作用する.
- RNF126は乳がんにおけるmTORC1シグナル伝達を阻害する潜在的治療標的である.
- RNF126-ILF3軸に関するさらなる研究は,がん治療の新たな戦略を明らかにする可能性があります.
さらに関連する動画
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K

